Similarly, PAIP1 downregulation increased the CFU capacity of these primary stem cells, an effect that was not further enhanced with mTOG-Ψ co-treatment, supporting the functional interaction between these factors in HR-MDS cells. Here, PAIP1 is linked to myelodysplastic syndrome.